Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
基本信息
- 批准号:10024589
- 负责人:
- 金额:$ 50.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:CD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell physiologyCellsCharacteristicsChromatinChromatin ModelingConsequentialismDataDependenceEffector CellEpigenetic ProcessExposure toGenerationsGenetic TranscriptionGenomeGoalsHeterogeneityHumanImmunityIn SituInfectionInfrastructureLaboratoriesLongevityLymphocyteLymphoidMaintenanceMalignant NeoplasmsMediatingMemoryPopulationRegulationRoleSiteSourceT cell differentiationT memory cellT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTechnologyTestingTherapeuticTissuesTumor ImmunityTumor-Infiltrating LymphocytesVaccinesVirus Diseasesbasecancer immunotherapyclinically relevantcytotoxiceffector T cellexperimental studyflexibilityimmunopathologyin vivomemory CD4 T lymphocytenovelpathogenprogramsresponsesmall hairpin RNAstemtranscription factortumortumor microenvironment
项目摘要
PROJECT SUMMARY / ABSTRACT
Project 3 (Goldrath)
In response to infection, many cellular factors cooperate to direct T cells through their expansion and
differentiation to effector cells that mediate pathogen clearance and memory cells that persist to provide long-
lived host protection from reinfection. Harnessing the functionality and longevity of memory T cells is the basis
for some vaccines and has become an attractive approach in cancer immunotherapy. However, the memory T
cell pool is heterogeneous, and it is currently unclear which subsets confer optimal protection during malignancy
or infection and how these subsets are transcriptionally programmed. We propose to define the transcriptional
and chromatin regulatory factors of memory T cell subset differentiation following infection and identify those that
promote accumulation and function of anti-tumor cytotoxic lymphocytes. Further, we will explore the relationship
between changes in chromatin configuration and memory T cell-specific transcriptional programs. We propose
highly collaborative Aims which leverage the expertise, infrastructure and technologies unique to the Crotty-
Pipkin-Goldrath laboratories and Cores. Specifically, we will: (1) Resolve the functional heterogeneity and
transcriptional programming of circulating CD8 memory T cell populations. (2) Define the transcriptional and
epigenetic programming of stem-like memory, effector, and tissue-resident CD8 T cell subsets in tumors. (3)
Resolve the roles of Blimp1 and Bcl6 in programming distinct CD4 memory T cell populations. (4) Dissect the
mechanism(s) by which the chromatin regulatory factor CTCF instructs memory T cell differentiation. By
developing an understanding of the factors that control differentiation and function of memory T cell subsets, it
may be possible to induce or regulate their activity in the context of infection, malignancy, and immunopathology.
项目摘要 /摘要
项目3(Goldrath)
响应感染,许多细胞因子合作,通过其扩展和
区分介导病原体清除率和记忆细胞的效应细胞,这些细胞持续存在长期
生命的宿主保护免受再感染。利用记忆T细胞的功能和寿命是基础
对于某些疫苗,并且已成为癌症免疫疗法的一种有吸引力的方法。但是,内存t
细胞池是异质的,目前尚不清楚哪些子集在恶性肿瘤期间提供最佳保护
或感染以及这些子集是如何通过转录编程的。我们建议定义转录
感染后记忆T细胞子集分化的染色质调节因素,并确定
促进抗肿瘤细胞毒性淋巴细胞的积累和功能。此外,我们将探索关系
在染色质配置的变化与内存T细胞特异性转录程序之间。我们建议
高度协作的目标,利用Crotty-独有的专业知识,基础架构和技术
Pipkin-Goldrath实验室和核心。具体而言,我们将:(1)解决功能异质性和
循环CD8记忆T细胞种群的转录编程。 (2)定义转录和
肿瘤中类茎状记忆,效应子和组织居民CD8 T细胞子集的表观遗传编程。 (3)
解决Blimp1和Bcl6在编程不同的CD4存储T细胞群体中的作用。 (4)剖析
染色质调节因子CTCF指导记忆T细胞分化的机制。经过
对控制记忆T细胞子集的分化和功能的因素建立理解,IT
在感染,恶性肿瘤和免疫病理学的背景下,可能有可能诱导或调节其活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ananda W Goldrath其他文献
Ananda W Goldrath的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ananda W Goldrath', 18)}}的其他基金
Ubiquitin ligase regulation of tissue-resident T cell and anti-tumor activity
泛素连接酶对组织驻留 T 细胞的调节和抗肿瘤活性
- 批准号:
10726015 - 财政年份:2023
- 资助金额:
$ 50.91万 - 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
- 批准号:
10683278 - 财政年份:2020
- 资助金额:
$ 50.91万 - 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
- 批准号:
10591871 - 财政年份:2020
- 资助金额:
$ 50.91万 - 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
- 批准号:
10224894 - 财政年份:2020
- 资助金额:
$ 50.91万 - 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
- 批准号:
10488590 - 财政年份:2020
- 资助金额:
$ 50.91万 - 项目类别:
Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection
急性和慢性感染中组织驻留记忆 T 细胞命运的分子决定因素
- 批准号:
10214451 - 财政年份:2018
- 资助金额:
$ 50.91万 - 项目类别:
Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection
急性和慢性感染中组织驻留记忆 T 细胞命运的分子决定因素
- 批准号:
10453786 - 财政年份:2018
- 资助金额:
$ 50.91万 - 项目类别:
相似国自然基金
肺部IFN-γ通过上调CXC趋化因子募集Th1与CD8阳性T淋巴细胞的作用及机制研究
- 批准号:81970013
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
FOXA1 通过 ARID1A 调节前列腺癌中的细胞因子信号传导和免疫景观
- 批准号:
10681898 - 财政年份:2023
- 资助金额:
$ 50.91万 - 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
- 批准号:
10755205 - 财政年份:2023
- 资助金额:
$ 50.91万 - 项目类别:
Defining Optimal Radiotherapy Dose and Fractionation in Combination with Preoperative Immuno-Chemotherapy in Early-Stage Triple Negative Breast Cancer
确定早期三阴性乳腺癌的最佳放疗剂量和分割与术前免疫化疗相结合
- 批准号:
10512391 - 财政年份:2023
- 资助金额:
$ 50.91万 - 项目类别:
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
新辅助免疫放疗治疗 HPV 介导的口咽癌
- 批准号:
10682257 - 财政年份:2023
- 资助金额:
$ 50.91万 - 项目类别:
Immune determinants of pediatric HIV/SIV reservoir establishment and maintenance
儿科 HIV/SIV 病毒库建立和维持的免疫决定因素
- 批准号:
10701467 - 财政年份:2023
- 资助金额:
$ 50.91万 - 项目类别: